Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Action Plan for Stroke in Europe 2018–2030
2018 Standout
A new taxonomy for describing and defining adherence to medications
2012 Standout
The Economic Costs of Type 2 Diabetes: A Global Systematic Review
2015
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
El cumplimiento terapéutico en las dislipemias medido mediante monitores electrónicos. ¿Es eficaz un calendario recordatorio para evitar los olvidos?
2007
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial
2012
Medication Compliance and Persistence: Terminology and Definitions
2007 Standout
Type 2 diabetes
2017 Standout
Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy
2008
Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
2011 Standout
Gender and racial disparities in adherence to statin therapy: A meta-analysis
2013
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review
2007
Medication Adherence: WHO Cares?
2011 Standout
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
2006
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
2012
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Dapagliflozin compared with other oral anti‐diabetes treatments when added to metformin monotherapy: a systematic review and network meta‐analysis
2013
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial
2020
Interventions for enhancing medication adherence
2014 Standout
Long‐term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add‐on therapy to metformin in patients with type 2 diabetes: 4‐year data
2015
Medication adherence initiatives — Part I
2007
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes
2013
Works of Michael Pollack being referenced
Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus
2011
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life
2009
Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy
2005
The effects of hypertension and obesity on total health-care expenditures of diabetes patients in the United States
2012